On-Demand CME Videos
Vitiligo Pearls and the Patient Conversation: Insights for PAs and NPs: An Online Activity
About
Vitiligo Pearls and The Patient Conversation: Insights for PA's and NP's: An Online Activity
This activity is supported by an educational grant from Incyte.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
June 26, 2024
July 7, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Define the current available and emerging therapies for the treatment of vitiligo
Describe issues in vitiligo diagnostics and approaches for improving the patient experience
Identify approaches for PA/NP cross-collaboration with rest of care team throughout the vitiligo care continuum
Intended Audience
Faculty
Karan Lal, DO, MS, FAAD
Director of Pediatric and Cosmetic Dermatology
Affiliated Dermatology
Scottsdale, AZ
Francine Phillips, MPAS, PA-C
Florida Medical Clinic
Land 'O Lakes, FL
E. James Song, MD, FAAD
Co-Chief Medical Officer and Director of Clinical Research, Frontier Dermatology
Mill Creek, WA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Advisory Board: Incyte, Galderma, Aphyn Biologics, Verrica, Cerave
Speaker's Bureau or Honoraria: Abbvie, Galderma, Incyte, Boehringer, Verrica
No relevant financial relationships with any Ineligible Company in the past 24 months.
Advisory Board: AbbVie, Alpyn, Amgen
Grant/Research Support: SUN Pharma, Dermbiont, AbbVie, BMS, Amgen, Apogee, Moonlake, Janssen, Corevitas, Target, Aslan
Consultant: AbbVie, Alpyn, Amgen
Speakers’ Bureau or Honoraria: AbbVie, Alpyn, Amgen
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.